Lipocine Inc (LPCN)

NASDAQ
0.9288
+0.0137(+1.50%)
After Hours
0.9200
-0.0088(-0.9475%)
- Real-time Data
  • Volume:
    574,536
  • Bid/Ask:
    0.9004/0.9200
  • Day's Range:
    0.8712 - 0.9492

LPCN Overview

Prev. Close
0.9151
Day's Range
0.8712-0.9492
Revenue
50K
Open
0.9101
52 wk Range
0.8032-2.27
EPS
-0.22
Volume
574,536
Market Cap
82M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
602,006
P/E Ratio
-
Beta
0.38
1-Year Change
-51.88%
Shares Outstanding
88,290,650
Next Earnings Date
Mar 10, 2022
What is your sentiment on Lipocine Inc?
or
Market is currently closed. Voting is open during market hours.

Lipocine Inc Company Profile

Employees
13

Lipocine Inc. is a clinical-stage biopharmaceutical company. The Company is focused on applying its oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The Company has a portfolio of product candidates designed to produce pharmacokinetic (PK) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects and eliminate gastrointestinal interactions that limit bioavailability. The Company's lead product candidate, TLANDO, is an oral testosterone replacement therapy (TRT) comprised of testosterone undecanoate (TU). Its additional pipeline candidates includes LPCN 1144, an oral prodrug of bioidentical testosterone comprised of TU for the treatment of non-cirrhotic non-alcoholic steatohepatitis (NASH) which is in Phase II testing and TLANDO XR, an oral TRT product comprised of testosterone tridecanoate (TT), which has completed Phase II trials.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellSellStrong Sell
Technical IndicatorsSellSellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • ALYI
    0
    • 🚀
      1
      • LPCN IA going down...
        0
        • This stock made me crazy
          0
          • Breakthrough in Pharmaceutical! when does production begin?
            0
            • Don't buy.Waste of money.
              7
              • huge buy
                0
                • good news
                  0
                  • some bad news there in a lawsuit
                    4
                    • they won
                      0
                  • Hello guys, just in now with LCPN any TP target soon?¿
                    0
                    • 3.50 to 4.00 $
                      0
                    • 0
                    • 5$
                      0
                  • A LOT of issues with the news release today. Company had to remove release from website and the fda approval is still tentative.
                    1
                    • 4 tomorrow
                      0
                      • Im waiting on that approval
                        0
                        • is this a good stock to invest in! st what price should I enter?
                          0
                          • yes very good one
                            0
                          • and it's a perfect time
                            0
                          • now
                            0
                        • Approval date is delayed for few weeks
                          0
                          • if it goes into after hours I’m thinking it most likely got approved. This is based on previous PDUFA run up stocks. Most bad PR is released immediately if on a Friday, no idea why but if your look at TRVN, FENC, TCDA, Etc they all follow the same trend.
                            1
                            • ↗️ Or ↘️ in few mins
                              0
                              • what is going with this one?
                                0
                                • what do you think guys? Any experts here?
                                  0
                                  • Will keep fluctuating upwards towards approval, do not hold Beyond approval. My advice is buy the dips sell the highs ajd keep doing that
                                    0
                                • Big news coming soon obviously.
                                  0
                                  Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                  Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.